WELLNEX Life, in partnership with OneLife Botanicals, has launched a medicinal cannabis brand, Wellness Life, under the Special Access Scheme (SAS).
Wellness Life began selling last month, with prescriptions being dispensed by registered medical professionals and available in pharmacies through The Entourage Effect, a medicinal cannabis distributor.
The brand offers a full range of high-quality Australian medicinal cannabis products, accessible via the SAS.
Wellnex’s medical advisors Dr Mihindu Jayasuriya and Dr Tony Farag are providing training and education to pharmacists and practitioners, to boost knowledge about Wellness Life products.
CEO George Karafotias said, “the launch of Wellness Life is an exciting development, and we are well positioned to take advantage of the growing demand for prescription medicinal cannabis”.
Data shows the medicinal cannabis market in Australia is projected to reach A$537.9 million in 2024, with a compound growth rate of 4.58% from 2024 to 2029, potentially reaching A$673 million by 2029.
